Jean Descamps was 26 years old when he walked into Providence Milwaukie Hospital outside Portland, Oregon, in December 2023, sick with opioid withdrawal and asking for help. He didn’t get it. According to NPR’s investigation, hospital staff labeled him a “malingerer” — a word pulled from psychiatry that means, stripped of its clinical varnish, we think you are faking this for something you want. When it came time to discharge him, staff told the police officer called in to remove him from the building that “a bus station is fine.” Bodycam audio obtained by NPR captures an officer on scene saying, plainly, “That guy does not need to be dead right now.” He was dead within hours.
That sentence should stop you. It’s supposed to.
The hospital didn’t fail Jean Descamps by accident. It failed him on schedule, the way it’s built to fail the next person who walks through that door tonight.
That’s not a metaphor. It’s a description of a system that NPR reports treats more than 40 million Americans for a diagnosable addiction disorder, and lets over 80% of the people who need care never receive any. It’s a system in which only one in five physicians say they’re even interested in treating opioid use disorder — addiction to opioids like fentanyl, heroin, or prescription painkillers — in the first place. Descamps wasn’t unlucky. He was typical. He is what happens, on a bad enough day, to someone the system was never built to catch.
”Malingerer” Is a Word the System Reaches for on Purpose
Emergency departments are supposed to be the place where the safety net still holds — the one door that has to open, no matter what’s in your bloodstream or your chart. For people with substance use disorders, that door too often opens onto a diagnosis instead of care. “Malingerer” isn’t a slip of the tongue. It’s a specific, weighted clinical accusation: that a patient is manufacturing or exaggerating symptoms for secondary gain, most commonly assumed in addiction cases to mean drugs. Once it lands in a chart, it changes everything that happens next — pain isn’t treated, withdrawal isn’t managed, and a young man in medical distress becomes, in the eyes of the people paid to help him, a problem to be moved along. “A bus station is fine” is what that verdict sounds like out loud.
This is where the numbers stop being abstract. NPR reports that 43% of healthcare workers still wrongly believe that medications for opioid use disorder — buprenorphine and methadone, the two medicines with the strongest evidence behind them for keeping people alive — simply “substitute one drug for another.” That belief isn’t a fringe opinion held by a few burned-out staff. It’s held by nearly half the workforce standing between a person in crisis and the one intervention proven to reduce their risk of dying. Alcohol and drug disorders kill more than 250,000 Americans a year, according to that same reporting, and two-thirds of people who die of overdose had at least one documented moment where the system touched them and failed to intervene. Descamps was one of those moments. He wasn’t hidden from the system. He was standing inside it, asking.
If you’ve ever sat in triage doubled over from withdrawal, watched a nurse’s face change the moment your history came up on the screen, or heard a version of “there’s nothing we can do for you here” that really meant “we’ve already decided what you are” — you already know this isn’t new information. You’ve lived the version of this story that didn’t make the news. Descamps’ case is notable not because it’s rare, but because someone happened to be wearing a body camera.
Descamps’ case is notable not because it’s rare, but because someone happened to be wearing a body camera.
The Same Stigma, Recycled for Fifty Years
None of this started in an Oregon ER in 2023. It started in the 1970s, when methadone maintenance treatment — a medication that has been keeping people with opioid use disorder alive and stable for over half a century — first scaled up in American cities and ran straight into “not in my backyard” opposition from the neighborhoods asked to host it. Methadone clinics were zoned into industrial strips and forgotten corners of town, wrapped in daily-dosing requirements and surveillance that no other medication for a chronic disease has ever carried — nobody stands in line every morning at a pharmacy counter to prove they took their insulin or their blood pressure pills. The clinics survived, but the framing stuck: methadone wasn’t treatment, it was “trading one addiction for another.” That is not a paraphrase. It is, per the NPR and JAMA Network Open reporting behind this piece, the exact phrase 43% of healthcare workers still use about buprenorphine today. Fifty years, one medication swapped for another, same sentence. The stigma that kept methadone locked behind chain-link fences and daily check-ins is the same stigma that got a 26-year-old called a malingerer and pointed toward a bus station. It didn’t evolve. It just found a new drug to attach itself to.
Even When the System Says Yes, It Finds a Way to Say No
Say a person clears every hurdle Descamps never got the chance to. Say a doctor writes the prescription. A new JAMA Network Open study followed 1,428 adults given their first buprenorphine prescription for opioid use disorder between 2020 and 2024, and found that even that isn’t the end of the obstacle course. The study tracked what researchers call “pharmacy abandonment” — plain language: the prescription gets written, but the patient never actually picks it up, so the medicine never reaches them at all. That rate climbed from 19% to 37% over those four years. Across the full study, more than a quarter of prescriptions — 25.8% — were never dispensed within 30 days of being written, a window that matters enormously to someone trying to stay stable through withdrawal.
The gap isn’t random, either, and this is where the JAMA data gets specific enough to be damning: patients with commercial insurance — the plans most people consider “good” coverage — abandoned their prescriptions at a rate of 51.8%, more than three times the rate for Medicare Advantage patients, who abandoned at 29.4%. The difference tracked closely with pharmacy deductibles: patients who abandoned their prescriptions faced average deductibles of $483.80, compared to $296.40 for those who didn’t. Translated out of insurance-speak: the amount of money a person has to pay out of pocket before their plan kicks in was, on its own, enough to decide whether a life-saving medication got picked up or left behind at the counter. A doctor did their job. A pharmacy had the medication in stock. And the person still didn’t get it, because the number at the register was too high on a day when they had nothing left to negotiate with.
This is the quieter cousin of what happened to Jean Descamps. He was turned away with a label. A quarter of the people who make it past that point are turned away by a price tag. Both are treated, functionally, as acceptable outcomes by a system that was never redesigned to close either gap. You can read more about how medication-based treatment and recovery pathways are supposed to work — and where they keep breaking — because understanding the mechanism is the first thing that makes it possible to fight it.
Bryan Braddock Left the State to Get What His Own City Couldn’t Give Him
Not every story here ends at a bus station. Bryan Braddock has been in recovery for 20 years. He’s now a city councilman in Florence, South Carolina, and according to WMBF News, he had to leave the state entirely — traveling to Illinois for faith-based treatment — because nothing available to him at home could meet what he needed. He got better anyway. Today he helps decide how Florence spends roughly $2.3 million in opioid settlement money through 2040, funds paid out by the companies whose products fueled the crisis in the first place. Florence’s mayor, Lethonia Barnes, frames the stakes in a sentence that could sit at the top of every hospital’s intake protocol: addiction is “a sickness” that requires help, not incarceration, according to the same WMBF report.
Braddock’s story is not a counterargument to Descamps’. It’s proof the outcome was never inevitable — proof that somewhere out there, on a given day, with the right door open, the same system can work. He had to cross a state line to find that door. That’s not a triumph of the system; it’s an indictment of how narrow the door is everywhere else, and a reminder that geography still decides who lives and who doesn’t. In Arizona, where the overdose death rate has climbed to an all-time high of 43.5 per 100,000 people, according to Axios Phoenix reporting — now roughly double the national rate, and higher than West Virginia’s — there is no guarantee that door exists at all, in any state, in any city, on any given night. The opioid crisis doesn’t distribute its exits evenly. It never has.
It’s proof the outcome was never inevitable — proof that somewhere out there, on a given day, with the right door open, the same system can work.
What’s Still Real Tonight — and What Isn’t Negotiable
Here is what doesn’t require an act of Congress or a change in hospital culture to be true tonight: buprenorphine and methadone are real, evidence-backed medications, they work, and a person seeking them has the right to ask a provider or a local health department directly about same-day or low-barrier access — some clinics exist specifically to route around the pharmacy abandonment problem the JAMA data describes, dispensing on-site rather than sending you to a counter with a deductible attached. If a hospital or clinic treats you like a diagnosis instead of a person, you are allowed to ask for a patient advocate, a second opinion, or simply to leave and try somewhere else. That option didn’t exist for Jean Descamps in the state he was in. It exists for you.
None of that erases what happened in Milwaukie, Oregon. A 26-year-old man told a hospital the truth about what was wrong with him, and the hospital decided he was lying. It documented that decision in a chart. It said the words out loud to a police officer, who understood immediately what was about to happen and said so on tape. And then it happened anyway, because nothing in the system was built to stop it once the label had been applied.
That’s the part worth sitting with — not as a tragedy that occurred, but as a design that functioned exactly as intended. The hospital did not misfire. It did the thing hospitals like it do every day, to people the reporting says outnumber the population of several states combined, and it did it fast enough that a man who was alive at intake was dead before the next shift change. Jean Descamps didn’t fall through a crack in the system. He was shown the door the system built for him, and someone told him a bus station would do.
Sources Cited
- 01.B
- 02.ABuprenorphine prescription abandonment, 2020-2024JAMA Network Open
- 03.B
Filed Under
psychologytreatmentsocial-culturalStigmaMAT — BuprenorphineMAT — MethadoneInvestigative JournalismOpioid Settlement
Keep up with the reporting.
One email each morning with the stories that put days like this in context.